NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Gross Profit

Annual Gross Profit:

$2.30B+$468.20M(+25.59%)
December 31, 2024

Summary

  • As of today, NBIX annual gross profit is $2.30 billion, with the most recent change of +$468.20 million (+25.59%) on December 31, 2024.
  • During the last 3 years, NBIX annual gross profit has risen by +$1.19 billion (+107.33%).
  • NBIX annual gross profit is now at all-time high.

Performance

NBIX Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Quarterly Gross Profit:

$676.20M+$112.80M(+20.02%)
June 30, 2025

Summary

  • As of today, NBIX quarterly gross profit is $676.20 million, with the most recent change of +$112.80 million (+20.02%) on June 30, 2025.
  • Over the past year, NBIX quarterly gross profit has increased by +$101.60 million (+17.68%).
  • NBIX quarterly gross profit is now at all-time high.

Performance

NBIX Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

TTM Gross Profit:

$2.46B+$101.60M(+4.31%)
June 30, 2025

Summary

  • As of today, NBIX TTM gross profit is $2.46 billion, with the most recent change of +$101.60 million (+4.31%) on June 30, 2025.
  • Over the past year, NBIX TTM gross profit has increased by +$398.40 million (+19.32%).
  • NBIX TTM gross profit is now at all-time high.

Performance

NBIX TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

NBIX Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+25.6%+17.7%+19.3%
3Y3 Years+107.3%+83.0%+94.3%
5Y5 Years+197.2%+127.0%+140.3%

NBIX Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+107.3%at high+79.0%at high+81.6%
5Y5-Yearat high+197.2%at high+192.5%at high+143.4%
All-TimeAll-Timeat high>+9999.0%at high+2004.8%at high+2873.5%

NBIX Gross Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$676.20M(+20.0%)
$2.46B(+4.3%)
Mar 2025
-
$563.40M(-8.0%)
$2.36B(+2.7%)
Dec 2024
$2.30B(+25.6%)
$612.20M(+0.6%)
$2.30B(+5.0%)
Sep 2024
-
$608.50M(+5.9%)
$2.19B(+6.1%)
Jun 2024
-
$574.60M(+14.3%)
$2.06B(+7.2%)
Mar 2024
-
$502.50M(+0.1%)
$1.92B(+5.2%)
Dec 2023
$1.83B(+26.1%)
$501.80M(+3.9%)
$1.83B(+5.9%)
Sep 2023
-
$483.00M(+10.5%)
$1.73B(+6.5%)
Jun 2023
-
$437.00M(+7.2%)
$1.62B(+4.3%)
Mar 2023
-
$407.80M(+1.8%)
$1.56B(+7.2%)
Dec 2022
$1.45B(+30.9%)
$400.40M(+6.0%)
$1.45B(+7.0%)
Sep 2022
-
$377.80M(+2.2%)
$1.35B(+7.0%)
Jun 2022
-
$369.50M(+22.1%)
$1.27B(+7.3%)
Mar 2022
-
$302.70M(-0.7%)
$1.18B(+6.5%)
Dec 2021
$1.11B(+7.9%)
$304.90M(+5.5%)
$1.11B(+5.9%)
Sep 2021
-
$289.00M(+2.0%)
$1.05B(+3.5%)
Jun 2021
-
$283.20M(+22.5%)
$1.01B(-1.4%)
Mar 2021
-
$231.20M(-4.8%)
$1.03B(-0.2%)
Dec 2020
$1.03B(+32.8%)
$242.80M(-4.3%)
$1.03B(+0.3%)
Sep 2020
-
$253.60M(-14.9%)
$1.02B(+3.4%)
Jun 2020
-
$297.90M(+27.9%)
$990.17M(+13.4%)
Mar 2020
-
$232.90M(-2.8%)
$873.35M(+12.5%)
Dec 2019
$773.21M(+73.2%)
$239.51M(+8.9%)
$776.16M(+16.4%)
Sep 2019
-
$219.87M(+21.4%)
$666.61M(+11.7%)
Jun 2019
-
$181.08M(+33.4%)
$596.95M(+16.7%)
Mar 2019
-
$135.71M(+4.4%)
$511.48M(+14.7%)
Dec 2018
$446.35M(+180.4%)
$129.96M(-13.5%)
$445.91M(+8.8%)
Sep 2018
-
$150.21M(+57.1%)
$409.71M(+28.3%)
Jun 2018
-
$95.61M(+36.3%)
$319.23M(+39.2%)
Mar 2018
-
$70.14M(-25.2%)
$229.30M(+44.5%)
Dec 2017
$159.17M(>+9900.0%)
$93.76M(+57.0%)
$158.68M(+146.3%)
Sep 2017
-
$59.73M(+950.6%)
$64.43M(+1399.7%)
Jun 2017
-
$5.68M(+1262.6%)
$4.30M(+350.8%)
Mar 2017
-
-$489.00K(+0.6%)
-$1.71M(-40.0%)
Dec 2016
$0.00(0.0%)
-$492.00K(-20.6%)
-$1.22M(-22.2%)
Sep 2016
-
-$408.00K(-25.9%)
-$1.00M(-19.6%)
Jun 2016
-
-$324.00K(>-9900.0%)
-$838.00K(-9.5%)
Mar 2016
-
$0.00(+100.0%)
-$765.00K(0.0%)
Dec 2015
$0.00(+100.0%)
-$270.00K(-10.7%)
-$765.00K(-6.4%)
Sep 2015
-
-$244.00K(+2.8%)
-$719.00K(-3.9%)
Jun 2015
-
-$251.00K(>-9900.0%)
-$692.00K(-6.6%)
Mar 2015
-
$0.00(+100.0%)
-$649.00K(+21.5%)
Dec 2014
-$827.00K(-136.8%)
-$224.00K(-3.2%)
-$827.00K(-2751.7%)
Sep 2014
-
-$217.00K(-4.3%)
-$29.00K(-115.4%)
Jun 2014
-
-$208.00K(-16.9%)
$188.00K(-52.5%)
Mar 2014
-
-$178.00K(-131.0%)
$396.00K(-31.0%)
Dec 2013
$2.25M(>+9900.0%)
$574.00K(>+9900.0%)
$574.00K(>+9900.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2012
$0.00(-100.0%)
$0.00(0.0%)
$1.88M(-62.3%)
Sep 2012
-
$0.00(0.0%)
$4.99M(-89.3%)
Jun 2012
-
$0.00(-100.0%)
$46.48M(0.0%)
Mar 2012
-
$1.88M(-39.5%)
$46.48M(-18.3%)
Dec 2011
$76.72M(+139.3%)
$3.11M(-92.5%)
$56.88M(-15.3%)
Sep 2011
-
$41.50M(>+9900.0%)
$67.12M(+68.9%)
Jun 2011
-
$0.00(-100.0%)
$39.73M(-9.7%)
Mar 2011
-
$12.27M(-8.1%)
$44.01M(+37.3%)
Dec 2010
$32.06M
$13.35M(-5.3%)
$32.06M(+71.4%)
DateAnnualQuarterlyTTM
Sep 2010
-
$14.10M(+229.3%)
$18.71M(+308.4%)
Jun 2010
-
$4.28M(+1217.8%)
$4.58M(+2934.4%)
Mar 2010
-
$325.00K(>+9900.0%)
$151.00K(+138.1%)
Dec 2009
-$226.00K(+93.8%)
$0.00(+100.0%)
-$396.00K(0.0%)
Sep 2009
-
-$26.00K(+82.4%)
-$396.00K(+74.9%)
Jun 2009
-
-$148.00K(+33.3%)
-$1.58M(+41.5%)
Mar 2009
-
-$222.00K(>-9900.0%)
-$2.70M(-9.0%)
Dec 2008
-$3.63M(+55.6%)
$0.00(+100.0%)
-$2.48M(0.0%)
Sep 2008
-
-$1.21M(+4.5%)
-$2.48M(+15.7%)
Jun 2008
-
-$1.27M(>-9900.0%)
-$2.94M(+28.2%)
Mar 2008
-
$0.00(0.0%)
-$4.09M(+37.5%)
Dec 2007
-$8.18M(-128.5%)
$0.00(+100.0%)
-$6.55M(0.0%)
Sep 2007
-
-$1.67M(+30.9%)
-$6.55M(-1.8%)
Jun 2007
-
-$2.42M(+1.6%)
-$6.43M(-60.2%)
Mar 2007
-
-$2.46M(>-9900.0%)
-$4.01M(-157.8%)
Dec 2006
$28.67M(-74.8%)
$0.00(+100.0%)
-$1.56M(0.0%)
Sep 2006
-
-$1.56M(>-9900.0%)
-$1.56M(>-9900.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$113.80M(+45.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$78.09M(-42.3%)
$0.00(0.0%)
$0.00(+100.0%)
Sep 2004
-
$0.00(0.0%)
-$11.95M(0.0%)
Jun 2004
-
$0.00(0.0%)
-$11.95M(0.0%)
Mar 2004
-
$0.00(+100.0%)
-$11.95M(0.0%)
Dec 2003
$135.39M(+805.8%)
-$11.95M(>-9900.0%)
-$11.95M(+66.3%)
Sep 2003
-
$0.00(0.0%)
-$35.50M(+35.2%)
Jun 2003
-
$0.00(0.0%)
-$54.75M(+25.6%)
Mar 2003
-
$0.00(+100.0%)
-$73.62M(+17.0%)
Dec 2002
$14.95M(-61.3%)
-$35.50M(-84.4%)
-$88.71M(-36.3%)
Sep 2002
-
-$19.25M(-2.0%)
-$65.06M(-52.9%)
Jun 2002
-
-$18.87M(-25.0%)
-$42.54M(-16.8%)
Mar 2002
-
-$15.09M(-27.3%)
-$36.41M(-10.3%)
Dec 2001
$38.59M(+211.5%)
-$11.85M(-462.9%)
-$33.02M(-24.4%)
Sep 2001
-
$3.27M(+125.6%)
-$26.55M(+28.2%)
Jun 2001
-
-$12.74M(-8.9%)
-$37.00M(-25.6%)
Mar 2001
-
-$11.70M(-117.5%)
-$29.45M(-29.5%)
Dec 2000
$12.39M(+200.1%)
-$5.38M(+25.0%)
-$22.74M(-11.3%)
Sep 2000
-
-$7.18M(-38.2%)
-$20.44M(-24.9%)
Jun 2000
-
-$5.19M(-4.0%)
-$16.36M(-12.5%)
Mar 2000
-
-$4.99M(-62.3%)
-$14.54M(-17.6%)
Dec 1999
-$12.38M(-114.7%)
-$3.08M(+0.7%)
-$12.37M(-55.8%)
Sep 1999
-
-$3.10M(+8.1%)
-$7.94M(+6.3%)
Jun 1999
-
-$3.37M(-19.6%)
-$8.48M(-10.4%)
Mar 1999
-
-$2.82M(-308.6%)
-$7.68M(-33.2%)
Dec 1998
-$5.77M(-192.2%)
$1.35M(+137.2%)
-$5.77M(-1012.5%)
Sep 1998
-
-$3.64M(-41.2%)
-$518.30K(-105.4%)
Jun 1998
-
-$2.58M(-184.7%)
$9.62M(-44.4%)
Mar 1998
-
-$904.60K(-113.7%)
$17.30M(-36.6%)
Dec 1997
$6.26M(-5.9%)
$6.60M(+1.5%)
$27.30M(-9.9%)
Sep 1997
-
$6.50M(+27.5%)
$30.30M(+15.2%)
Jun 1997
-
$5.10M(-44.0%)
$26.30M(-2.2%)
Mar 1997
-
$9.10M(-5.2%)
$26.90M(+33.2%)
Dec 1996
$6.65M
$9.60M(+284.0%)
$20.20M(+90.6%)
Sep 1996
-
$2.50M(-56.1%)
$10.60M(+30.9%)
Jun 1996
-
$5.70M(+137.5%)
$8.10M(+237.5%)
Mar 1996
-
$2.40M
$2.40M

FAQ

  • What is Neurocrine Biosciences, Inc. annual gross profit?
  • What is the all-time high annual gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual gross profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly gross profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. TTM gross profit year-on-year change?

What is Neurocrine Biosciences, Inc. annual gross profit?

The current annual gross profit of NBIX is $2.30B

What is the all-time high annual gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual gross profit is $2.30B

What is Neurocrine Biosciences, Inc. annual gross profit year-on-year change?

Over the past year, NBIX annual gross profit has changed by +$468.20M (+25.59%)

What is Neurocrine Biosciences, Inc. quarterly gross profit?

The current quarterly gross profit of NBIX is $676.20M

What is the all-time high quarterly gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly gross profit is $676.20M

What is Neurocrine Biosciences, Inc. quarterly gross profit year-on-year change?

Over the past year, NBIX quarterly gross profit has changed by +$101.60M (+17.68%)

What is Neurocrine Biosciences, Inc. TTM gross profit?

The current TTM gross profit of NBIX is $2.46B

What is the all-time high TTM gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high TTM gross profit is $2.46B

What is Neurocrine Biosciences, Inc. TTM gross profit year-on-year change?

Over the past year, NBIX TTM gross profit has changed by +$398.40M (+19.32%)
On this page